Kentucky Subject | Diseases | House | Bills | Introduced

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
KYHB438Intro
25%
Amend KRS 158.832 to include a definition for "undesignated glucagon"; amend KRS 158.838 to allow health care practitioners to prescribe undesignated glucagon in the name of a school to be maintained for use by a school nurse or trained school employ...
[Detail][Text][Discuss]
2024-03-27
To House Appropriations and Revenue Committee
KYHB642Intro
25%
Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for coronary calcium imaging testing; provide that coronary calcium imaging testing shall not be considered investigational or experimental; a...
[Detail][Text][Discuss]
2024-02-22
To House Committee On Committees
KYHB617Intro
25%
Create new sections of KRS Chapter 210 to define terms; establish the Kentucky Youth Mobile Crisis Response Program within the Cabinet for Health and Family Services; set requirements for mobile crisis response teams; require the cabinet to develop p...
[Detail][Text][Discuss]
2024-02-20
To House Committee On Committees
KYHB352Intro
25%
Amend KRS 218B.010 to add additional conditions to the list of qualifying medical conditions for the use of medicinal cannabis.
[Detail][Text][Discuss]
2024-01-23
To House Committee On Committees
KYHB322Intro
25%
Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for the testing of hepatitis C virus infection in pregnant women and the treatment of hepatitis C virus infection in postpartum women; amend K...
[Detail][Text][Discuss]
2024-01-22
To House Committee On Committees
KYHB273Intro
25%
Create a new section of KRS Chapter 205 to require the Department for Medicaid Services and any managed care organization contracted to provide Medicaid benefits to provide comprehensive coverage for the treatment of obesity and inform Medicaid enrol...
[Detail][Text][Discuss]
2024-01-16
To House Committee On Committees
KYHB229Intro
25%
Create a new section of KRS 217.005 to 217.215, the Kentucky Food, Drug, and Cosmetic Act, to define terms; require products that are known to be or could act as gene therapy to be labeled with the words "Potential Gene Therapy Product" or "Gene Ther...
[Detail][Text][Discuss]
2024-01-10
To House Committee On Committees
Syndicate content
feedback